Skip to main content
MNPR logo

MNPR · Monopar Therapeutics · Executive Compensation

Track MNPR — free
$71.42 +4.20 (+6.25%) At close · Nov 6
Market Cap
$479.38M
Shares
6.71M
Volume · Nov 6 94.21K Avg daily vol (3M) 164.19K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Chandler D. Robinson $10,637,821
Andrew Cittadine $4,706,431
Andrew J. Cittadine $4,706,431
Quan Vu $2,101,314
Fiscal 2024
Executive Total
Chandler D. Robinson $1,144,480
Andrew Cittadine $554,796
Andrew J. Cittadine $554,796
Karthik Radhakrishnan $320,160
Quan Vu —
Fiscal 2023
Executive Total
Chandler D. Robinson $1,778,667
Andrew J. Cittadine $911,161
Andrew Cittadine $911,161
Kim R. Tsuchimoto $848,441
Karthik Radhakrishnan —
Fiscal 2022
Executive Total
Chandler D. Robinson $1,601,448
Andrew J. Cittadine $752,326
Andrew Cittadine $752,326
Kim R. Tsuchimoto $695,128
Fiscal 2020
Executive Total
Chandler D. Robinson $1,588,564
Andrew P. Mazar $872,571
Kim R. Tsuchimoto $523,349
Fiscal 2019
Executive Total
Chandler D. Robinson $541,250
Andrew P. Mazar $465,500
Kim R. Tsuchimoto $183,225

Executive changes

Person Change Filed
Quan Vu Appointed 2025-03-03
Quan Vu Appointed 2025-03-03
Quan Vu Appointed 2025-03-03
Karthik Radhakrishnan Terminated 2025-03-03
Lavina Talukdar Appointed 2025-02-24
Michael J. Brown Resigned 2025-02-24
Karthik Radhakrishnan Appointed 2024-05-24
Kim R. Tsuchimoto Retired 2024-05-24

Leadership

Key facts CIK 1645469 CUSIP 61023L207 13F (30d) 28 filings 24 filers Visit website Investor relations